Shares of Eisai Co., Ltd. (OTCMKTS:ESALY – Get Free Report) passed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $61.51 and traded as high as $63.29. Eisai shares last traded at $61.51, with a volume of 331,800 shares changing hands.
Eisai Price Performance
The company has a current ratio of 2.20, a quick ratio of 1.77 and a debt-to-equity ratio of 0.10. The firm has a market capitalization of $17.64 billion, a price-to-earnings ratio of 70.70, a P/E/G ratio of 2.46 and a beta of 0.31. The company’s 50 day moving average is $61.51 and its 200-day moving average is $61.51.
About Eisai
Eisai Co, Ltd. is a research-driven global pharmaceutical company headquartered in Tokyo, Japan. Founded in 1941 by Toyoji Naito, Eisai focuses on the discovery, development, manufacture and commercialization of prescription medicines and related healthcare products. The company emphasizes neuroscience and oncology as core therapeutic areas and invests in both small-molecule and biologic research to address unmet medical needs.
Among its well-known products, Eisai developed and markets Aricept (donepezil), a widely used treatment for the symptoms of Alzheimer’s disease, and LENVIMA (lenvatinib), an oncology therapy for several tumor types.
Featured Stories
- Five stocks we like better than Eisai
- A personal warning from Martin Weiss (Please read)
- SpaceX IPO Confirmed: Claim Your Stake Today
- Iran isn’t the real war
- This coin has everything going for it
- Only 500 people today…
Receive News & Ratings for Eisai Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eisai and related companies with MarketBeat.com's FREE daily email newsletter.
